insulin calculator

FDA grants DreaMed's de novo request for device-friendly diabetes software
By Dave Muoio | 09:52 am | June 18, 2018
The FDA has granted Isreal-based DreaMed Diabetes a de novo request for its artificial intelligence-powered software for providers managing patients with Type 1 diabetes.
Eli Lilly gets FDA clearance for insulin dose calculator app
By Jonah Comstock | 02:28 pm | January 19, 2017
Updated with statement from Eli Lilly Indianapolis-based pharma company Eli Lilly recently recieved FDA 510K clearance for a new mobile app called Go Dose, a diabetes management and insulin dosing app for users of Humalog, Lilly's rapid-acting insulin.